Can sciatica induced by disc herniation be treated with tumor necrosis factor alpha blockade?
Goupille
Philippe
P
François Rabelais de Tours University, EA 3853 Immuno-Pharmaco-Génétique des Anticorps thérapeutiques, Tours Cedex 9, France. goupille@med.univ-tours.fr
Mulleman
Denis
D
Paintaud
Gilles
G
Watier
Hervé
H
Valat
Jean-Pierre
JP
D000068879:Adalimumab; D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D004195:Disease Models, Animal; D006801:Humans; D000069285:Infliximab; D007405:Intervertebral Disc Displacement / Q000150:complications* / Q000503:physiopathology; D051381:Rats; D012585:Sciatica / Q000188:drug therapy* / Q000209:etiology* / Q000503:physiopathology; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors* / Q000502:physiology
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab; D000068879:Adalimumab